Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$111,656
in 2 filings

Net −$111,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Douglas Earl Martin −$63K SVP, General Counsel sold 6% of stake
  2. Parker Geoffrey M. −$49K CHIEF FINANCIAL OFFICER sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2019-09-05 Chang David D President and CEO Other acquisition +9,402 1,154,302
2019-09-05 Chang David D President and CEO Other acquisition +9,391 2,195,469
2019-09-05 Kazam Joshua A Director Other acquisition +8,217 1,429,052
2019-09-03 Amado Rafael EVP of R&D and CMO Grant or award +105,162 105,162
2019-09-03 Amado Rafael EVP of R&D and CMO Grant or award · Stock Option (Right to Buy) +160,630 160,630
2019-07-30 MOORE ALISON Chief Technical Officer Option exercise +11,819 $2.27 $27K 77,192
2019-07-30 MOORE ALISON Chief Technical Officer Sale −11,819 $29.85 $353K 65,373
2019-07-30 MOORE ALISON Chief Technical Officer Option exercise · Stock Option (Right to Buy) −11,819 767,029
2019-07-29 MOORE ALISON Chief Technical Officer Option exercise +23,815 $2.27 $54K 89,188
2019-07-29 MOORE ALISON Chief Technical Officer Sale −23,815 $29.39 $700K 65,373
2019-07-29 MOORE ALISON Chief Technical Officer Option exercise · Stock Option (Right to Buy) −23,815 778,848
2019-07-26 MOORE ALISON Chief Technical Officer Option exercise +13,193 $2.27 $30K 78,566
2019-07-26 MOORE ALISON Chief Technical Officer Sale −13,193 $29.18 $385K 65,373
2019-07-26 MOORE ALISON Chief Technical Officer Option exercise · Stock Option (Right to Buy) −13,193 802,663
2019-07-18 Kazam Joshua A Director Other acquisition +8,217 1,420,835
2019-07-18 Chang David D President and CEO Other acquisition +9,402 1,144,900
2019-07-18 Chang David D President and CEO Other acquisition +9,391 2,186,078
2019-07-10 Kazam Joshua A Director Other acquisition +5,590 1,412,618
2019-07-10 Chang David D President and CEO Other acquisition +6,388 2,176,687
2019-06-28 MOORE ALISON Chief Technical Officer Option exercise +27,816 $2.27 $63K 65,373

Page 20 of 23 · 451 trades